Abstract
The primary objective of the study was to explore the effectiveness of Vertebral Axial Decompression (VAX-D) in treating patients with chronic low back pain (CLBP) as a safe and competent therapeutic method. Also, to determine the quality of life in alleviating chronic lumbar pain using mechanical Lumbar traction force applied to the lumbar spine. A systematic review and meta-analysis involving detailed literature survey on Vertebral Axial Decompression (VAX-D) therapy for patients with chronic low back pain were conducted in three databases namely MEDLINE, EMBASE and Cochrane Library from (January 1994 to February 2019). Studies supporting the outcomes with qualitative statistical analysis on chronic low back pain and Lumbar traction were retrieved. We retrieved sixteen randomized controlled trials (RCTs) for systematic review, and 6 studies were found to be eligible for inclusion in meta-analysis with a sample size of 486 patients receiving Lumbar traction. Among them, one study was found to be high quality that detailed the positive relationship between reduction of pain intensity after VAX-D therapy. However, most of the studies are unsuccessful in demonstrating an improvement towards the patient's mobility or quality of life. There is no reliable indication of the efficacy of VAX-D therapy for chronic low back pain patients. Studies on VAX-D had methodological errors and inadequate data for profound statistical analysis. Further, there was no evidence to show the dosage requirement, patient position, and settings on the VAX-D table that led to observed outcomes. Any prospect of research focusing on LBP morbidity should enable to distinguish between symptom duration and pattern with accurate standard methods. Therefore, more studies validating the effective treatment strategies in the management of patients with chronic low back pain are warranted.
Highlights
Chronic low back (CLBP) exists as one of the significant causes of disability worldwide
Treatment with Vertebral Axial Decompression (VAX-D) for eight weeks showed a decrease in pain intensity (RMDQ) at discharge and at the 30- and 180-day follow-up period
VAX-D achieves best results when used for 20 daily sessions 5 days per week
Summary
Chronic low back (CLBP) exists as one of the significant causes of disability worldwide. There is an increasing prevalence of CLBP [1], their effective treatment modalities remain elusive. CLBP is experienced by the illnesses affecting the bony lumbar spine, ligaments around the backbone and discs, intervertebral discs (discs between the vertebrae), spinal cord and nerves, muscles of the low back, internal organs, and the skin covering the lumbar area. The early LBP is a symptom, not a disease, and it has a wide range of causes. Chronic LBP was prevalent and was found to be approximately 84%. In most of the cases, they are mild to moderate and tentative to repeat without affecting the daily activities, and the majority of the individuals with LBP do not seek medical care.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
